Response of cutaneous lesion of mantle cell lymphoma to lenalidomide.
Hematology Unit, Bnai Zion Medical Center, Golomb 47 st.34108, Haifa, Israel.
Elena
E
Mishchenko
Dina
D
Attias
Tamar
T
Tadmor
D000369:Aged, 80 and over; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D000077269:Lenalidomide; D020522:Lymphoma, Mantle-Cell / Q000188:drug therapy* / Q000473:pathology*; D008297:Male; D012867:Skin / Q000187:drug effects* / Q000473:pathology; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000556:secondary*; D013792:Thalidomide / Q000031:analogs & derivatives* / Q000627:therapeutic use
D007155:Immunologic Factors; D013792:Thalidomide; D000077269:Lenalidomide